Meveol hypothiocyanite/lactoferrin regulatory update

The EC granted Orphan Drug designation for Alaxia's Meveol to treat cystic fibrosis. The inhaled combination of hypothiocyanite and lactoferrin, which the company said is designed to deliver natural a...